Opiant Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 10, 2022

Rhea-AI Summary

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will release its financial results for Q1 2022 on May 10, 2022. The announcement will occur after market close, followed by a conference call at 4:30 PM ET. Investors can access the call at 1-877-407-0792 (U.S.) or 1-201-689-8263 (International) and join the live webcast online. Opiant is known for developing NARCAN® Nasal Spray and is focused on creating new treatments for addiction and drug overdose.

News Market Reaction – OPNT

-6.37%

-6.37% Session move

In the trading session that priced this news, OPNT declined 6.37%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SANTA MONICA, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, will report its financial results for the first quarter ended March 31, 2022, after the financial markets close on Tuesday, May 10, 2022.  

The Company’s management team is scheduled to host a conference call and webcast with slides at 4:30 p.m. ET on Tuesday, May 10, 2022. To access the call, please dial 1-877-407-0792 in the U.S. or 1-201-689-8263 outside the U.S. and provide the conference ID number: 13728852. To access the live webcast, please visit https://viavid.webcasts.com/starthere.jsp?ei=1542632&tp_key=dabaa0a667. Following the live webcast, an archived version of the call will be available on the website.

Tuesday May 10 @ 4:30 pm ET

Domestic:	1-877-407-0792
International:	1-201-689-8263
Conference ID:	13728852
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1542632&tp_key=dabaa0a667

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
For more information visit: www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com

FAQ

When will Opiant Pharmaceuticals report its Q1 2022 financial results?

Opiant Pharmaceuticals will report its Q1 2022 financial results on May 10, 2022, after market close.

What time is Opiant Pharmaceuticals' conference call on May 10, 2022?

The conference call for Opiant Pharmaceuticals is scheduled for 4:30 PM ET on May 10, 2022.

How can I access the Opiant Pharmaceuticals conference call?

To access the conference call, dial 1-877-407-0792 in the U.S. or 1-201-689-8263 internationally, using conference ID 13728852.